Analyst Consensus
- Current Price
- 389.04 $
- Target (Low)
- 220.00 $
- Target (Mean)
- 335.74 $
- Target (High)
- 450.00 $
- Recommendation
- Buy
- Number of Analysts
- 31
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 25 |
|---|
| Hold | 5 |
|---|
| Sell | 1 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 30.9%
- Operating Margin
- 35.0%
- Gross Margin
- 50.0%
- Return on Equity (ROE)
- 66.8%
- Return on Assets (ROA)
- 22.8%
- Revenue Growth
- 23.8%
- Earnings Growth
- 40.8%
- Debt/Equity
- 35.28
- Current Ratio
- 2.54
- Beta
- 1.87
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 17, 2026 | Citigroup | Buy → Buy |
| Jun 15, 2026 | Oppenheimer | Outperform → Outperform |
| Jun 11, 2026 | Barclays | Equal-Weight → Equal-Weight |
| Jun 10, 2026 | Cantor Fitzgerald | Overweight → Overweight |
| Jun 9, 2026 | UBS | Buy → Buy |
| Jun 1, 2026 | Wells Fargo | Overweight → Overweight |